Vivimed Labs

1 Like

According to last quarterly results (which was dismal), they have mentioned that they have LOST control over most of their subsidiaries including UQUIFA and SONEAS.
Is that the reason for the low revenue and what would this mean for the company going forward as their major revenue (API and CDMO) was coming from mentioned subsidiaries?

Cam anyone throw a light on this?